Gainers
Avenue Therapeutics (NASDAQ:ATXI) stock moved upwards by 17.2% to $0.7 during Friday's after-market session. The company's market cap stands at $14.5 million.
Surgalign Holdings Inc (NASDAQ: SRGA) has priced its previously announced underwritten public offering of 43.47 million and warrants to purchase up to 32.6 million shares at a
Gainers
Avenue Therapeutics (NASDAQ:ATXI) stock increased by 17.2% to $0.7 during Thursday's after-market session. The company's market cap stands at $14.5 million.
Surgalign Holdings, Inc. (NASDAQ:SRGA), a global medical technology company focused on elevating the standard of care through the evolution of digital health, today announced it has acquired an equity interest in
Gainers
Tempest Therapeutics (NASDAQ:TPST) shares increased by 8.19% to $6.6 during Thursday's after-market session. The company's market cap stands at $45.6 million.